Surgical intervention or the control of drug-refractory epilepsy requires accurate analysis of invasive inspection intracranial EEG (iEEG) data. A multi-branch deep learning fusion model is proposed to identify epileptogenic signals from the epileptogenic area of the brain. The classical approach extracts multi-domain signal wave features to construct a time-series feature sequence and then abstracts it through the bi-directional long short-term memory attention machine (Bi-LSTM-AM) classifier. The deep learning approach uses raw time-series signals to build a one-dimensional convolutional neural network (1D-CNN) to achieve end-to-end deep feature extraction and signal detection. These two branches are integrated to obtain deep fusion features and results. Resampling is employed to split the imbalanced epileptogenic and non-epileptogenic samples into balanced subsets for clinical validation. The model is validated over two publicly available benchmark iEEG databases to verify its effectiveness on a private, large-scale, clinical stereo EEG database. The model achieves high sensitivity (97.78%), accuracy (97.60%), and specificity (97.42%) on the Bern-Barcelona database, surpassing the performance of existing state-of-the-art techniques. It is then demonstrated on a clinical dataset with an average intra-subject accuracy of 92.53% and cross-subject accuracy of 88.03%. The results suggest that the proposed method is a valuable and extremely robust approach to help researchers and clinicians develop an automated method to identify the source of iEEG signals.